Citadel Advisors’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.46M Buy
621,235
+131,547
+27% +$945K ﹤0.01% 2029
2025
Q1
$2.93M Buy
489,688
+392,025
+401% +$2.35M ﹤0.01% 2230
2024
Q4
$762K Buy
97,663
+88,016
+912% +$687K ﹤0.01% 3534
2024
Q3
$104K Buy
9,647
+603
+7% +$6.51K ﹤0.01% 4905
2024
Q2
$76.2K Sell
9,044
-122,847
-93% -$1.04M ﹤0.01% 5045
2024
Q1
$886K Sell
131,891
-508,880
-79% -$3.42M ﹤0.01% 3311
2023
Q4
$3.77M Buy
640,771
+580,166
+957% +$3.41M ﹤0.01% 1870
2023
Q3
$591K Sell
60,605
-74,162
-55% -$723K ﹤0.01% 3574
2023
Q2
$1.6M Sell
134,767
-1,161,005
-90% -$13.7M ﹤0.01% 2609
2023
Q1
$14M Sell
1,295,772
-558,548
-30% -$6.03M ﹤0.01% 1081
2022
Q4
$21.4M Buy
1,854,320
+522,040
+39% +$6.03M 0.01% 840
2022
Q3
$19.9M Buy
1,332,280
+260,766
+24% +$3.89M ﹤0.01% 829
2022
Q2
$9.67M Buy
1,071,514
+1,006,013
+1,536% +$9.07M ﹤0.01% 1307
2022
Q1
$491K Buy
+65,501
New +$491K ﹤0.01% 4466
2021
Q4
Sell
-14,340
Closed -$121K 6531
2021
Q3
$121K Buy
+14,340
New +$121K ﹤0.01% 5737
2021
Q2
Sell
-1,303,659
Closed -$11.1M 6470
2021
Q1
$11.1M Buy
1,303,659
+446,717
+52% +$3.82M ﹤0.01% 1355
2020
Q4
$9.62M Buy
856,942
+850,691
+13,609% +$9.55M ﹤0.01% 1276
2020
Q3
$59K Buy
6,251
+2,250
+56% +$21.2K ﹤0.01% 4361
2020
Q2
$7K Sell
4,001
-827
-17% -$1.45K ﹤0.01% 4559
2020
Q1
$8K Buy
+4,828
New +$8K ﹤0.01% 4755
2019
Q2
Sell
-5,182
Closed -$91K 4689
2019
Q1
$91K Buy
+5,182
New +$91K ﹤0.01% 4113
2018
Q4
Sell
-5,699
Closed -$235K 4544
2018
Q3
$235K Buy
+5,699
New +$235K ﹤0.01% 3646
2018
Q2
Sell
-9,350
Closed -$416K 4219
2018
Q1
$416K Buy
+9,350
New +$416K ﹤0.01% 3060